Webcasting The New Norm During COVID-19 As FDA Reschedules Opthalmic AdComm Panel
Executive Summary
In a sign of the times, regulators are holding an advisory committee meeting for an ophthalmic device online because of the pandemic.
You may also be interested in...
The Wait Is Over: US FDA Advisory Committees Returning To In-Person Meetings Come Fall
‘We’re coming back,’ Oncology Center of Excellence Director Richard Pazdur says. Office of New Drugs Director Peter Stein says transition from virtual to in person will be gradual because FDA is trying to be sensitive to adcomm members' need to schedule travel and demands on their time.
FDA Makes 2nd Attempt At Virtual MDUFA Public Meeting
For the second time in the past few months the US agency has rescheduled a webcast of a public meeting meant to start MDUFA V user-fee negotiations.
FDA To Virtually Convene Orthopedic Panel
In a sign the US FDA is trying to address key issues not related to COVID-19, the agency is bringing together an expert panel almost five months after it was originally slated to meet to discuss classifying a slew of orthopedic devices.